(Q38576506)

English

Clinical Activity, Toxicity, Biomarkers, and Future Development of CTLA-4 Checkpoint Antagonists

scientific article published on 03 June 2015

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26320062

retrieved

4 September 2017

title

Clinical Activity, Toxicity, Biomarkers, and Future Development of CTLA-4 Checkpoint Antagonists (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4 September 2017

0 references

2

Jedd D Wolchok

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4 September 2017

Margaret K Callahan

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26320062

retrieved

4 September 2017

publication date

3 June 2015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

26320062

retrieved

4 September 2017

volume

42

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26320062

retrieved

4 September 2017

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26320062

retrieved

4 September 2017

page(s)

573-586

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26320062

retrieved

4 September 2017

cites work

CTLA-4 can function as a negative regulator of T cell activation

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/1074-7613(94)90071-X

Randomized phase II study comparing 4 monthly doses of ipilimumab (MDX-010) as a single agent or in combination with a single dose of docetaxel in patients with hormone-refractory prostate cancer

1 reference

18 October 2022

https://opencitations.net/index/coci/api/v1/citations/10.1200/JCO.2006.24.18_SUPPL.4609

Identifiers

DOI

10.1053/J.SEMINONCOL.2015.05.008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26320062

retrieved

4 September 2017

PubMed publication ID

26320062

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26320062

retrieved

4 September 2017

(Q38576506)

Clinical Activity, Toxicity, Biomarkers, and Future Development of CTLA-4 Checkpoint Antagonists

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)